Skip to main content

Table 3 Cost-effectiveness analysis of thermotherapy vs. glucantime

From: Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia

Strategy C IC E IE IC/IE Dominance CEA
DALYs averted
 Thermotherapy 290,187 140.75   2062
 Glucantime 508,797 218,610 119.99 −20.76 −10,530 Dominated 4241
Patients Cured
 Thermotherapy 290,187 4124 70,4
 Glucantime 508,797 218,610 6016 1892 115,5 84,6
  1. C cost, IC incremental cost, E effectiveness, IE incremental effectiveness, CEA cost effectiveness average